[VRDN] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
29-Sep-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -62.96%
YoY-
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 695 944 1,631 889 501 1,301 984 -5.62%
PBT -11,230 -9,011 -5,834 -1,839 -3,152 -1,637 -880 52.83%
Tax 133 362 113 0 0 0 0 -
NP -11,230 -9,011 -5,834 -1,839 -3,152 -1,637 -880 52.83%
Tax Rate - - - - - - - -
Total Cost 11,925 9,955 7,465 2,728 3,653 2,938 1,863 36.24%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -1,615.83 -954.56 -357.69 -206.86 -629.14 -125.84 -89.43 61.95%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -5.42 -4.40 -4.06 -2.56 -5.82 -6.05 -4.68 2.47%
EPS Diluted -5.42 -4.40 -4.06 -2.56 -5.82 -6.05 -4.68 2.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.